Warning letter
Eagle Pharmacy, Inc.: warning letter of Oct 13, 2016
FDA warning letter 496586 · New Orleans District Office
Key facts
| Reference number | 496586 |
|---|---|
| Company | Eagle Pharmacy, Inc. |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Oct 13, 2016 |
| Posted date | Oct 18, 2016 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 210, 211.192, 200.10(b), 211.42(c)(10)(iv), 211.113(b), 210.1(b) |
| Inspection city | Hoover |
| Inspection ZIP | 35244 |
| Inspection start date | Aug 3, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: